AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Bioasis Technologies Inc.

$0 -$0.00 (-50.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
7.94K
AVG Volume
68.08K
Trailing/Forward PE
-0.12/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
2026-11-02
Primary Exchange
Other OTCUS
Revenue (CAD)
02M4M6M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Revenue (CAD) by quarter
PeriodRevenue (CAD)
23 Q3148.94K
23 Q2120.44K
23 Q10
22 Q40
22 Q337.73K
22 Q20
22 Q10
21 Q40
21 Q30
21 Q24.08M
Net Income (CAD)
-2M-1M01M2M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Net Income (CAD) by quarter
PeriodNet Income (CAD)
23 Q3-985.67K
23 Q2-1.09M
23 Q1-233.21K
22 Q4-566.76K
22 Q3-1.27M
22 Q2-580.29K
22 Q1-540.65K
21 Q4-1.09M
21 Q3897.52K
21 Q21.95M
Operating Income (CAD)
-4M-2M02M4M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
23 Q3-698.86K
23 Q2-899.66K
23 Q1-629.65K
22 Q4-2.14M
22 Q3-776.27K
22 Q2-1.19M
22 Q1-1.04M
21 Q4-1.4M
21 Q3-828.54K
21 Q23.06M
EBITDA (CAD)
-2M-1M01M2M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
23 Q3-664.03K
23 Q2-828.58K
23 Q126.88K
22 Q4-1.59M
22 Q3-762.62K
22 Q2-411.95K
22 Q1-774.96K
21 Q4-1.54M
21 Q3913.38K
21 Q21.97M
Cash Flows (CAD)
-2M-1M01M2M3M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
23 Q3-443.31K
23 Q2-223.69K
23 Q1-588.89K
22 Q4-680.64K
22 Q3-945.92K
22 Q2-1.21M
22 Q1-802.54K
21 Q4788.6K
21 Q3-860.44K
21 Q22.24M
EPS (CAD)
-0.0200.020.0421 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF EPS (CAD) by quarter
PeriodEPS (CAD)
23 Q3-0.01
23 Q2-0.01
23 Q1-0
22 Q4-0.01
22 Q3-0.02
22 Q2-0.01
22 Q1-0.01
21 Q4-0.02
21 Q30.01
21 Q20.03
Expenses (CAD)
0500K1M1.5MR&DSG&ACapex21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Expenses (CAD) by quarter
PeriodExpenses (CAD)
23 Q3847.8K
23 Q21.02M
23 Q1629.65K
22 Q4845.84K
22 Q3814K
22 Q21.19M
22 Q1788.92K
21 Q4936.52K
21 Q3828.54K
21 Q21.02M
Cash & Debt (CAD)
01M2M3M4MCashLong Term DebtShort Term Debt21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
23 Q3156.51K
23 Q2568.23K
23 Q1764.97K
22 Q41.73M
22 Q32.59M
22 Q23.53M
22 Q11.87M
21 Q42.74M
21 Q32.68M
21 Q21.94M
Debt ratios
-10-5051021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Debt ratios by quarter
PeriodDebt ratios
23 Q3-0.67
23 Q2-0.46
23 Q1-0.37
22 Q4-0.05
22 Q30.16
22 Q20.97
22 Q1-3.09
21 Q4-7.92
21 Q3-2.88
21 Q25.15
Margins
-50%0%50%100%19 Q319 Q420 Q120 Q220 Q320 Q421 Q222 Q323 Q223 Q3
BIOAF Margins by quarter
PeriodMargins
23 Q3-48.29%
23 Q273.99%
22 Q3100%
21 Q2100%
20 Q4100%
20 Q3100%
20 Q2100%
20 Q1100%
19 Q499.88%
19 Q3100%
Return on Capital
-500%0%500%1000%1500%21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Return on Capital by quarter
PeriodReturn on Capital
23 Q336.55%
23 Q264.1%
23 Q110.87%
22 Q429.56%
22 Q381.59%
22 Q2189.48%
22 Q11064.55%
21 Q4-267.91%
21 Q3240.08%
21 Q2-346.44%
Shares Outstanding
020M40M60M80M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Shares Outstanding by quarter
PeriodShares Outstanding
23 Q378.21M
23 Q278.21M
23 Q172.91M
22 Q472.91M
22 Q372.14M
22 Q272.14M
22 Q172.14M
21 Q472.14M
21 Q364.89M
21 Q264.94M
Book Value Per Share (CAD)
-0.04-0.0200.0221 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
23 Q3-0.03
23 Q2-0.02
23 Q1-0.03
22 Q4-0.03
22 Q3-0.02
22 Q2-0
22 Q1-0
21 Q40.01
21 Q30.01
21 Q2-0.01
Total Assets (CAD)
02M4M6M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOAF Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
23 Q31.76M
23 Q22.32M
23 Q11.29M
22 Q42.27M
22 Q33.01M
22 Q24.04M
22 Q12.35M
21 Q43.28M
21 Q33.13M
21 Q22.39M
PE Ratio
10203040med 27.17Mar 21Apr 21Jun 21Jul 21Sep 21Oct 21Nov 21
BIOAF PE Ratio by quarter
PeriodPE Ratio
Nov 2117.6
Nov 2118.04
Nov 2117.91
Nov 2116.29
Oct 2116.92
Oct 2116.54
Oct 2117.53
Oct 2118.31
Oct 2118.78
Sep 2117.27
Sep 2115.34
Sep 2117.05
Sep 2115.15
Aug 2128.66
Aug 2128.58
Aug 2127.14
Aug 2128.53
Jul 2131.04
Jul 2130.48
Jul 2138.09
Jul 2139.84
Jul 2139.49
Jun 2133
Jun 2132.9
Jun 2138.09
Jun 2130.38
May 2123.37
May 2122.84
May 2121.18
May 2121.86
Apr 2124.85
Apr 2127.17
Apr 2130.64
Apr 2134.72
Apr 2134.64
Mar 2131.28
Mar 2133.77
Mar 2135.37
Mar 2132.7
Free Cash Flow Yield
-20000%-15000%-10000%-5000%0%med -9049.1%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BIOAF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-17852.75%
Sep 26-17900.89%
Aug 26-17811.01%
Aug 26-17989.85%
Aug 26-17848.11%
Aug 26-17767.04%
Jul 26-17670.67%
Jul 26-17570.23%
Jul 26-17660.84%
Jul 26-17497.47%
Jul 26-17459.96%
Jun 26-17451.71%
Jun 26-17514.42%
Jun 26-17701.5%
Jun 26-17765%
May 26-17958.93%
May 26-17922.66%
May 26-18014.33%
May 26-18106.94%
May 26-18225.3%
Apr 26-18119%
Apr 26-18087.9%
Apr 26-8945.79%
Apr 26-8895.07%
Mar 26-8912.75%
Mar 26-9024.3%
Mar 26-9023.12%
Mar 26-9130.26%
Feb 26-9077.77%
Feb 26-9054.13%
Feb 26-9093.77%
Feb 26-9056.32%
Jan 26-9092.44%
Jan 26-9038.67%
Jan 26-8897.82%
Jan 26-8900%
Jan 26-9018.39%
Dec 25-9055.72%
Dec 25-8973.48%
Dec 25-8990.75%
Dec 25-8961.65%
Nov 25-8861.65%
Nov 25-8782.06%
Nov 25-8831.24%
Nov 25-8814.58%
Oct 25-8841.84%
Oct 25-8847.33%
Oct 25-8832%
Oct 25-8845.37%
Oct 25-8878.23%
Sep 25-8882.18%
Sep 25-8989.57%
Sep 25-8942.82%
Sep 25-8955.75%
Aug 25-9011.69%
Aug 25-8957.89%
Aug 25-8961.98%
Aug 25-9001.01%
Aug 25-8979.53%
Jul 25-9038.34%
Jul 25-9024.5%
Jul 25-9046.72%
Jul 25-9115.13%
Jun 25-9051.49%
Jun 25-9015.5%
Jun 25-9117.75%
Jun 25-18088.82%
May 25-18027.05%
May 25-18037.3%
May 25-17729.76%
May 25-4443.64%
May 25-4481.67%
Apr 25-4470.05%
Apr 25-4475.03%
Apr 25-4465.25%
Apr 25-4351.37%
Mar 25-4325.22%
Mar 25-4313.88%
Mar 25-4307.94%
Mar 25-4310.19%
Feb 25-4281.33%
Feb 25-17418.69%
Feb 25-17462.42%
Feb 25-17332.72%
Jan 25-8524.98%
Jan 25-8633.78%
Jan 25-8550.95%
Jan 25-8587.9%
Jan 25-8572.15%
Dec 24-17183.56%
Dec 24-17231.39%
Dec 24-17403.01%
Dec 24-17498.09%
Nov 24-17686.83%
Nov 24-17722.28%
Nov 24-17581.33%
Sep 24-18272.78%
Aug 24-18362.9%
Aug 24-18335.29%
Aug 24-18109.46%
Price to Sales
00.050.10.150.2med 0.08Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BIOAF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.04
Sep 260.04
Aug 260.04
Aug 260.04
Aug 260.04
Aug 260.04
Jul 260.04
Jul 260.04
Jul 260.04
Jul 260.04
Jul 260.04
Jun 260.04
Jun 260.04
Jun 260.04
Jun 260.04
May 260.04
May 260.04
May 260.04
May 260.04
May 260.04
Apr 260.04
Apr 260.04
Apr 260.08
Apr 260.08
Mar 260.08
Mar 260.08
Mar 260.08
Mar 260.08
Feb 260.08
Feb 260.08
Feb 260.08
Feb 260.08
Jan 260.08
Jan 260.08
Jan 260.08
Jan 260.08
Jan 260.08
Dec 250.08
Dec 250.08
Dec 250.08
Dec 250.08
Nov 250.08
Nov 250.08
Nov 250.08
Nov 250.08
Oct 250.08
Oct 250.08
Oct 250.08
Oct 250.08
Oct 250.08
Sep 250.08
Sep 250.08
Sep 250.08
Sep 250.08
Aug 250.08
Aug 250.08
Aug 250.08
Aug 250.08
Aug 250.08
Jul 250.08
Jul 250.08
Jul 250.08
Jul 250.08
Jun 250.08
Jun 250.08
Jun 250.08
Jun 250.04
May 250.04
May 250.04
May 250.04
May 250.16
May 250.16
Apr 250.16
Apr 250.16
Apr 250.16
Apr 250.17
Mar 250.17
Mar 250.17
Mar 250.17
Mar 250.17
Feb 250.17
Feb 250.04
Feb 250.04
Feb 250.04
Jan 250.08
Jan 250.08
Jan 250.08
Jan 250.08
Jan 250.08
Dec 240.04
Dec 240.04
Dec 240.04
Dec 240.04
Nov 240.04
Nov 240.04
Nov 240.04
Sep 240.04
Aug 240.04
Aug 240.04
Aug 240.04
EV/EBITDA
020406080med 33.62Mar 21Apr 21Jun 21Jul 21Sep 21Oct 21Nov 21
BIOAF EV/EBITDA by quarter
PeriodEV/EBITDA
Nov 2134.33
Nov 2135.26
Nov 2134.99
Nov 2131.55
Oct 2132.88
Oct 2132.08
Oct 2134.18
Oct 2135.85
Oct 2136.84
Sep 2133.62
Sep 2129.54
Sep 2133.17
Sep 2129.12
Aug 2152.48
Aug 2152.33
Aug 2149.3
Aug 2152.21
Jul 2157.51
Jul 2156.33
Jul 2172.37
Jul 2176.07
Jul 2175.32
Jun 2161.64
Jun 2161.44
Jun 2172.37
Jun 2156.12
May 2116.91
May 2116.46
May 2115.06
May 2115.63
Apr 2118.16
Apr 2120.13
Apr 2123.07
Apr 2126.53
Apr 2126.46
Mar 2123.61
Mar 2125.72
Mar 2127.07
Mar 2124.82
Price/Operating Cashflow
020406080100med 30.16Dec 20Feb 21Apr 21Jun 21Aug 21Oct 21Nov 21
BIOAF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Nov 2115.66
Nov 2116.05
Nov 2115.94
Nov 2114.5
Oct 2115.06
Oct 2114.72
Oct 2115.6
Oct 2116.3
Oct 2116.71
Sep 2115.36
Sep 2113.66
Sep 2115.17
Sep 2113.48
Aug 2111.3
Aug 2111.27
Aug 2110.7
Aug 2111.25
Jul 2112.24
Jul 2112.02
Jul 2115.02
Jul 2115.71
Jul 2115.57
Jun 2113.01
Jun 2112.97
Jun 2115.02
Jun 2111.98
May 2156.41
May 2155.11
May 2151.13
May 2152.77
Apr 2159.97
Apr 2165.57
Apr 2173.95
Apr 2183.8
Apr 2183.61
Mar 2175.49
Mar 2181.5
Mar 2185.37
Mar 2178.93
Feb 2165.92
Feb 2166.11
Feb 2174.6
Feb 2163.52
Jan 2162.94
Jan 2172.7
Jan 2167.15
Jan 2156.88
Dec 2049.77
Dec 2047.06
Dec 2045.35
Dec 2043.6
Dec 2048.37
Price to Book
4050607080med 55.61Mar 21Apr 21May 21Jun 21Jul 21Jul 21Aug 21
BIOAF Price to Book by quarter
PeriodPrice to Book
Aug 2149.15
Aug 2149.03
Aug 2146.56
Aug 2148.93
Jul 2153.24
Jul 2152.28
Jul 2165.34
Jul 2168.34
Jul 2167.73
Jun 2156.6
Jun 2156.44
Jun 2165.34
Jun 2152.11
May 2147.13
May 2146.05
May 2142.72
May 2144.09
Apr 2150.11
Apr 2154.78
Apr 2161.78
Apr 2170.02
Apr 2169.85
Mar 2163.07
Mar 2168.09
Mar 2171.32
Mar 2165.95
Bioasis Technologies Inc.
BIOAF
Stockpicker

Video analysis: BIOAF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.